DrugPipeline.net has announced the addition of “Global Alopecia Drugs Market 2016-2020” research report to their website DrugPipeline.net

Bangalore, India -- (SBWire) -- 12/13/2016 --Alopecia is a loss of hair and can occur at any age across the genders. The exact cause of this disorder is unknown, but many factors are assumed to be responsible for developing alopecia. Few of the primary ones are a sedentary lifestyle, unhealthy diets, and side effects of certain medical treatments. Moreover, hormonal imbalance and aging increase the probability of developing a chronic disease like cancer, arthritis, depression, and hypertension, which would also lead to hair loss, especially among middle-to-late-aged people.

Report forecast the global alopecia drugs market to grow at a CAGR of 5.02% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global alopecia drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of alopecia drugs.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Global Alopecia Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- GlaxoSmithKline
- Johnson & Johnson
- Merck

Other prominent vendors
- Aclaris Therapeutics
- Actelion Pharmaceuticals
- Almirall
- AndroScience
- Anterios
- Aqua Pharmaceuticals
- Astellas Pharma
- Bayer HealthCare
- BERG Health
- BiologicsMD
- BioPharmX
- Celtaxsys
- Cipher Pharmaceuticals
- Concert Pharmaceuticals
- Cosmo Pharmaceuticals
- Dermira
- Elorac
- F. Hoffmann-La Roche
- Foamix
- Guthy-Renker
- Helix BioMedix
- Hygeia Therapeutics
- Hyundai Pharm
- Incyte
- Kasiak Research
- Kythera Biopharmaceuticals
- Mylan
- NovaLead Pharma
- Novan
- Oculus Innovative Sciences
- Paratek Pharmaceuticals
- Photocure
- Polichem
- Promius Pharma
- Ranbaxy Laboratories
- Reckitt Benckiser
- Regience
- Samumed
- RepliCel
- Skinvisible Pharmaceuticals
- Teva Pharmaceutical
- Versapharm
- XBiotech

Market driver
- Popularity of off-label and OTC drugs
- For a full, detailed list, view our report

Market challenge
- Limited availability of approved drugs
- For a full, detailed list, view our report

Market trend
- Emergence of laser technology and platelet-rich plasma (PRP) therapy
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 76 pages "Global Lithotripters Market 2016-2020" report covers Executive summary, Scope of the report, Market research methodology, Introduction, Overview: Alopecia, Pipeline portfolio, Market landscape, Key buying criteria, Market segmentation by ROA, Market segmentation by gender, Geographical segmentatio, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

For more information Visit at: http://www.drugpipeline.net/technavio/global-alopecia-drugs-market-2016-2020

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.